Carotid Artery Disease and Lower Extremities Artery Disease in Patients with Chronic Obstructive Pulmonary Disease
DOI:
https://doi.org/10.3889/oamjms.2019.576Keywords:
Airflow limitation, Carotid artery, C-reactive protein, Doppler ultrasonography, Lower limb arteriesAbstract
AIM: To assess the frequency of carotid artery disease (CAD) and lower extremities artery disease (LEAD) in patients with chronic obstructive pulmonary disease (COPD) and their relation to the severity of airflow limitation and the level of C-reactive protein (CRP).
METHODS: We performed a cross-sectional study including 60 patients with COPD (52 male, 8 female), aged 40 to 80 years, initially diagnosed according to the actual criteria. Also, 30 subjects in whom COPD was excluded, matched to COPD patients by sex, age, body mass index and smoking status, served as controls. All study subjects completed questionnaire and underwent pulmonary evaluation (dyspnea severity assessment, baseline and post-bronchodilator spirometry, gas analyses, and chest X-ray), angiological evaluation by Doppler ultrasonography and measurement of serum CRP level.
RESULTS: We found a statistically significant difference between the frequency of carotid plaques in COPD patients as compared to their frequency in controls (65% vs 30%; P = 0.002). The mean value of intima-media thickness (IMT) in COPD patients with CAD was significantly higher than its mean value in controls (0.8 ± 0.2 vs. 0.7 ± 0.2; P = 0.049). IMT value in COPD patients with CAD was significantly related to the degree of airflow limitation, i.e. to the degree of FEV1 decline (P = 0.000), as well as to the serum CRP level (P = 0.001). We found a statistically significant difference between the frequency of COPD patients with LEAD as compared to the frequency of LEAD in controls (78.3% vs 43.3%; P = 0.001). According to the Fontaine classification, COPD patients with LEAD were categorized in the stages I, IIA and IIB (53.3%, 30% and 16.7%, respectively), whereas all controls with LEAD were categorized in the Fontaine stage I. Among COPD patients with LEAD there was significant association between disease severity and clinical manifestations due to the vascular changes (P = 0.001) and serum CRP level (P = 0.001).
CONCLUSION: Our findings suggest higher prevalence and higher severity of vascular changes in COPD patients as compared to their prevalence and severity in non-COPD subjects. Prevalence and severity of vascular changes in COPD patients were significantly related to the severity of airflow limitation and serum CRP levels.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Executive Summary: Global Strategy for Diagnosis, Management, and Prevention of COPD - Updated 2018.
Budev MM, Arroliga AC, Wiedemann HP, Matthay RA. Cor Pulmonale: An Overview. Semin Respir Crit Care Med. 2003; 24(3):233-44. https://doi.org/10.1055/s-2003-41105 PMid:16088545
Sabit R, Bolton C. Sub-clinical left and right ventricular dysfunction in patients with COPD. Respir Med. 2010; 104(8):1171-1178. https://doi.org/10.1016/j.rmed.2010.01.020 PMid:20185285
Don DS, Man P. Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular diseasel. Can J Physiol Pharmacol. 2005; 83(1):8-13. https://doi.org/10.1139/y04-116 PMid:15759045
Anthony S, Fauci A, Braunwald E, Kasper D, Hauser S, Longo D et al. Principles of Harrison's Internal Medicine. 17th Ed. 2008; 1635-1642.
Lucas-Ramos P, Izquierdo-Alonso J, Rodriguez-Gonzalez J, et al. Chronic obstructive pulmonary disease as a cardiovascular risk factor. Results of a case-control study (CONSISTE study). Int J COPD. 2012; 7:679-686. https://doi.org/10.2147/COPD.S36222 PMid:23055717 PMCid:PMC3468057
Jeremy A, Kadiev S, Criner G, et al. Cardiac disease in Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc. 2008; 5(4):543-548. https://doi.org/10.1513/pats.200708-142ET PMid:18453369 PMCid:PMC2645333
Hunninghake D. Cardiovascular Disease in Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc. 2005; 2:44-49. https://doi.org/10.1513/pats.200410-050SF PMid:16113468
Finkelstein J, Cha E, Scharf S. Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. Int J COPD. 2009; 4:337- 349. https://doi.org/10.2147/COPD.S6400
Maclay JD, MacNee W. Cardiovascular disease in COPD. Chest. 2013; 143(3):798-807. https://doi.org/10.1378/chest.12-0938 PMid:23460157
Diez JM, Morgan JC, Garcia RJ. The association between COPD and heart failure risk: a review. Int J Chron Obstruct Pulmon Dis. 2013; 8:305-312. https://doi.org/10.2147/COPD.S31236 PMid:23847414 PMCid:PMC3700784
Kim SJ, Yoon DW, Lee EJ, et al. Carotid atherosclerosis in patients with untreated chronic obstructive pulmonary disease. NT J TUBERC LUNG DIS. 2011; 15(9):1265-1270. https://doi.org/10.5588/ijtld.10.0680 PMid:21943856
Sin DD, Paul Man SF. Why Are Patients with Chronic Obstructive Pulmonary Disease at Increased Risk of Cardiovascular Diseases? Circulation. 2003; 107:1514-1519. https://doi.org/10.1161/01.CIR.0000056767.69054.B3 PMid:12654609
Lin MS, Hsu KY, Chen YJ, Chen CR, Chen CM, Chen W. Prevalence and risk factors of asymptomatic peripheral arterial disease in patients with COPD in Taiwan. PLoS One. 2013; 8:e64714. https://doi.org/10.1371/journal.pone.0064714 PMid:23717654 PMCid:PMC3661545
Pecci R, Aguado J, Sanjurjo AB, Sanchez CP, Corbacho AM. Peripheral arterial disease in patients with chronic obstructive pulmonary disease. Int Angiol. 2012; 31:444-53.
Criqui MH, Denenberg JO, Langer RD, et al. The Epidemiology of Peripheral Arterial Disease: Importance of Identifying the Population at Risk. Vascular Medicine. 1997; 2(3):221-226. https://doi.org/10.1177/1358863X9700200310 PMid:9546971
Ness J, Aronow WS. Prevalence of Coexistence of Coronary Artery Disease, Ischemic Stroke, and Peripheral Arterial Disease in Older Persons, Mean Age 80 Years, in an Academic Hospital-Based Geriatrics Practice. Journal of the American Geriatrics Society. 1999; 47(10):1255-1256. https://doi.org/10.1111/j.1532-5415.1999.tb05208.x PMid:10522961
Pizarro C, Linnhoff F, Essen F, Pingel S, Schaefer CA, et al. Lower extremity and carotid artery disease in COPD. ERJ Open Res. 2016; 2:00037. https://doi.org/10.1183/23120541.00037-2016 PMid:28053972 PMCid:PMC5152848
Castagna O, Boussuges A, Nussbaum E, et al. Peripheral arterial disease: an underestimated aetiology of exercise intolerance in chronic obstructive pulmonary disease patients. Eur J Cardiovasc Prev Rehabil. 2008; 15(3):270-277. https://doi.org/10.1097/HJR.0b013e3282f009a9 PMid:18446087
Calculate your Body Mass Index. Available at: https://www.nhlbi.nih.gov (Accessed 08.12.2018).
World Health Organization. Guidelines for controlling and monitoring the tobbaco epidemic. Geneva: WHO, 1998.
Minette A. Questionnaire of the European Community for Coal and Steel (ECSC) on respiratory symptoms. 1987 - updating of the 1962 and 1967 questionnaires for studying chronic bronchitis and emphysema. Eur Respir J. 1989; 2:165-177.
European Community Respiratory Health Survey. Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Respiratory Health Survey (ECRHS). Eur Respir J. 1996; 9:687-695. https://doi.org/10.1183/09031936.96.09040687
Fletcher CM. Standardised questionnaire on respiratory symptoms: a statement prepared and approved by the MRC Committee on the Aetiology of Chronic Bronchitis (MRC breathlessness score). BMJ 1960; 2:1662.
Miller МР, Hankinson Ј, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005; 26:319-338. https://doi.org/10.1183/09031936.05.00034805 PMid:16055882
Lee W. General principles of carotid Doppler ultrasonography. Ultrasonography. 2014; 33(1):11-17. https://doi.org/10.14366/usg.13018 PMid:24936490 PMCid:PMC4058969
Hwang JY. Doppler ultrasonography of the lower extremity arteries: anatomy and scanning guidelines. Ultrasonography. 2017; 36(2):111-119. https://doi.org/10.14366/usg.16054 PMid:28219004 PMCid:PMC5381852
Weinberg I. FONTAINE CLASSIFICATION. Updated: March 7, 2018. Available at: http://www.angiologist.com/arterial-disease/fontaine-classification (Accessed 10.12. 2018).
Zureik M, Kauffmann F, Touboul PJ, et al. Association between peak expiratory flow and the development of carotid atherosclerotic plaques. Arch Intern Med. 2001; 161:1669-1676. https://doi.org/10.1001/archinte.161.13.1669 PMid:11434800
Shen TC, Chen W, Cheng-Li L, et al. Chronic Obstructive Pulmonary Disease is Associated with an Increased Risk of Peripheral Arterial Disease. 2014; 25:272-280.
Sadeka SH, Hassana AA, Abdelrahmanb G, et al. Subclinical cardiovascular changes in chronic obstructive pulmonary disease patients: Doppler ultrasound evaluation. Egyptian Journal of Bronchology. 2015; 9:140-145. https://doi.org/10.4103/1687-8426.158046
Barr RG, Ahmed FS, Carr JJ, et al. Subclinical atherosclerosis, airflow obstruction and emphysema: the MESA Lung Study. Eur Respir J. 2012; 39:846-854. https://doi.org/10.1183/09031936.00165410 PMid:22034646 PMCid:PMC3616898
Kim SJ, Yoon DW, Lee EJ, et al. Carotid atherosclerosis in patients with untreated chronic obstructive pulmonary disease. Int J Tuberc Lung Dis. 2011; 15:1265-1270. https://doi.org/10.5588/ijtld.10.0680 PMid:21943856
Pecci R, De La Fuente Aguado J, et al. Peripheral arterial disease in patients with chronic obstructive pulmonary disease. Int Angiol. 2012; 31:444-453.
Watz H, Waschki B, Boehme C, et al. Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med. 2008; 177:743-751. https://doi.org/10.1164/rccm.200707-1011OC PMid:18048807
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Daniela Buklioska-Ilievska, Jordan Minov, Nade Kochovska-Kamchevska, Irena Gigovska, Ana Doneva, Marjan Baloski (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
